NSCLC also acquire resistance through transforming to a small cell lung cancer (SCLC) phenotype, although given that these cells retain their ALK rearrangements, further investigation is required to determine why these transformations mediate resistance [152,153,154,155]. The gene discussed is ALK; the disease is non-small cell lung carcinoma.